_1711528829.png)
RUTINIB 5
Product Code: 18
Pack Size: 50'S
- Price: $50 ৳6100 ,
Each tablet contains Ruxolitinib 5mg as Ruxolitinib Phosphate INN.
Myelofibrosis: It is indicated for treatment of patients with intermediate or high-risk myelofibrosis (MF), including primary MF, post-polycythemia vera MF and post-essential thrombocythemia MF. Polycythemia Vera: Ruxolitinib is indicated for treatment of patients with polycythemia vera (PV) who have had an inadequate response to or are intolerant of hydroxyurea.
Major Ingredients
Each tablet contains Ruxolitinib 5mg as Ruxolitinib Phosphate INN.
Major Functionality
Myelofibrosis: It is indicated for treatment of patients with intermediate or high-risk myelofibrosis (MF), including primary MF, post-polycythemia vera MF and post-essential thrombocythemia MF. Polycythemia Vera: Ruxolitinib is indicated for treatment of patients with polycythemia vera (PV) who have had an inadequate response to or are intolerant of hydroxyurea.
Manufacture Information
Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.
